Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy

Abstract Background The obesity and lipid metabolism were previously proposed to be related with the clinical outcomes of metastatic renal cell carcinoma (mRCC). We tried to investigate the relationship between preoperative cholesterol level (PCL) and survival outcomes in patients with mRCC. Methods...

Full description

Bibliographic Details
Main Authors: Hakmin Lee, Yong June Kim, Eu Chang Hwang, Seok Ho Kang, Sung-Hoo Hong, Jinsoo Chung, Tae Gyun Kwon, Cheol Kwak, Hyeon Hoe Kim, Jong Jin Oh, Sang Chul Lee, Sung Kyu Hong, Sang Eun Lee, Seok-Soo Byun, KOrean Renal Cell Carcinoma (KORCC) Group
Format: Article
Language:English
Published: BMC 2017-05-01
Series:BMC Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12885-017-3322-5
_version_ 1828516952503484416
author Hakmin Lee
Yong June Kim
Eu Chang Hwang
Seok Ho Kang
Sung-Hoo Hong
Jinsoo Chung
Tae Gyun Kwon
Cheol Kwak
Hyeon Hoe Kim
Jong Jin Oh
Sang Chul Lee
Sung Kyu Hong
Sang Eun Lee
Seok-Soo Byun
KOrean Renal Cell Carcinoma (KORCC) Group
author_facet Hakmin Lee
Yong June Kim
Eu Chang Hwang
Seok Ho Kang
Sung-Hoo Hong
Jinsoo Chung
Tae Gyun Kwon
Cheol Kwak
Hyeon Hoe Kim
Jong Jin Oh
Sang Chul Lee
Sung Kyu Hong
Sang Eun Lee
Seok-Soo Byun
KOrean Renal Cell Carcinoma (KORCC) Group
author_sort Hakmin Lee
collection DOAJ
description Abstract Background The obesity and lipid metabolism were previously proposed to be related with the clinical outcomes of metastatic renal cell carcinoma (mRCC). We tried to investigate the relationship between preoperative cholesterol level (PCL) and survival outcomes in patients with mRCC. Methods We analysed the data of 244 patients initially treated with cyto-reductive nephrectomy after being diagnosed with mRCC. Patients were stratified into two groups according to the PCL cut-off level of 170 mg/dL. The postoperative survival rates were compared using Kaplan-Meier analysis and the possible predictors of patients’ cancer-specific survival (CSS) and overall survival (OS) were tested using multivariate Cox-proportional hazard models. Results The low cholesterol group showed significantly worse postoperative CSS (p = 0.013) and OS (p = 0.009) than the high cholesterol group. On multivariate analysis, low PCL was revealed as an independent predictor of worse CSS (hazard ratio [HR], 2.162; 95% CI, 1.221–3.829; p = 0.008) and OS (HR, 2.013; 95% CI, 1.206–3.361; p = 0.007). Subsequent subgroup analysis showed that these results were maintained in the clear cell subgroup but not in the non-clear cell subgroup. Conclusion Decreased PCL was significantly correlated with worse survival outcomes in patients with mRCC treated with cytoreductive nephrectomy. The underlined mechanism is still uncharted and requires further investigation.
first_indexed 2024-12-11T18:34:56Z
format Article
id doaj.art-f7486d3cd96a49728779675e6c7ffbda
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-12-11T18:34:56Z
publishDate 2017-05-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-f7486d3cd96a49728779675e6c7ffbda2022-12-22T00:54:48ZengBMCBMC Cancer1471-24072017-05-011711710.1186/s12885-017-3322-5Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomyHakmin Lee0Yong June Kim1Eu Chang Hwang2Seok Ho Kang3Sung-Hoo Hong4Jinsoo Chung5Tae Gyun Kwon6Cheol Kwak7Hyeon Hoe Kim8Jong Jin Oh9Sang Chul Lee10Sung Kyu Hong11Sang Eun Lee12Seok-Soo Byun13KOrean Renal Cell Carcinoma (KORCC) GroupDepartment of Urology, Seoul National University Bundang HospitalDepartment of Urology, Chungbuk National University College of MedicineDepartment of Urology, Chonnam National University Hwasun HospitalDepartment of Urology, Korea University School of MedicineDepartment of Urology, College of Medicine, The Catholic University of KoreaDepartment of Urology, National Cancer CenterDepartment of Urology, Kyungpook National University College of MedicineDepartment of Urology, Seoul National University HospitalDepartment of Urology, Seoul National University HospitalDepartment of Urology, Seoul National University Bundang HospitalDepartment of Urology, Seoul National University Bundang HospitalDepartment of Urology, Seoul National University Bundang HospitalDepartment of Urology, Seoul National University Bundang HospitalDepartment of Urology, Seoul National University Bundang HospitalAbstract Background The obesity and lipid metabolism were previously proposed to be related with the clinical outcomes of metastatic renal cell carcinoma (mRCC). We tried to investigate the relationship between preoperative cholesterol level (PCL) and survival outcomes in patients with mRCC. Methods We analysed the data of 244 patients initially treated with cyto-reductive nephrectomy after being diagnosed with mRCC. Patients were stratified into two groups according to the PCL cut-off level of 170 mg/dL. The postoperative survival rates were compared using Kaplan-Meier analysis and the possible predictors of patients’ cancer-specific survival (CSS) and overall survival (OS) were tested using multivariate Cox-proportional hazard models. Results The low cholesterol group showed significantly worse postoperative CSS (p = 0.013) and OS (p = 0.009) than the high cholesterol group. On multivariate analysis, low PCL was revealed as an independent predictor of worse CSS (hazard ratio [HR], 2.162; 95% CI, 1.221–3.829; p = 0.008) and OS (HR, 2.013; 95% CI, 1.206–3.361; p = 0.007). Subsequent subgroup analysis showed that these results were maintained in the clear cell subgroup but not in the non-clear cell subgroup. Conclusion Decreased PCL was significantly correlated with worse survival outcomes in patients with mRCC treated with cytoreductive nephrectomy. The underlined mechanism is still uncharted and requires further investigation.http://link.springer.com/article/10.1186/s12885-017-3322-5Renal cell carcinomaCholesterolSurvivalMetastasisHypercholesterolemia
spellingShingle Hakmin Lee
Yong June Kim
Eu Chang Hwang
Seok Ho Kang
Sung-Hoo Hong
Jinsoo Chung
Tae Gyun Kwon
Cheol Kwak
Hyeon Hoe Kim
Jong Jin Oh
Sang Chul Lee
Sung Kyu Hong
Sang Eun Lee
Seok-Soo Byun
KOrean Renal Cell Carcinoma (KORCC) Group
Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy
BMC Cancer
Renal cell carcinoma
Cholesterol
Survival
Metastasis
Hypercholesterolemia
title Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy
title_full Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy
title_fullStr Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy
title_full_unstemmed Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy
title_short Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy
title_sort preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto reductive nephrectomy
topic Renal cell carcinoma
Cholesterol
Survival
Metastasis
Hypercholesterolemia
url http://link.springer.com/article/10.1186/s12885-017-3322-5
work_keys_str_mv AT hakminlee preoperativecholesterollevelasanewindependentpredictivefactorofsurvivalinpatientswithmetastaticrenalcellcarcinomatreatedwithcytoreductivenephrectomy
AT yongjunekim preoperativecholesterollevelasanewindependentpredictivefactorofsurvivalinpatientswithmetastaticrenalcellcarcinomatreatedwithcytoreductivenephrectomy
AT euchanghwang preoperativecholesterollevelasanewindependentpredictivefactorofsurvivalinpatientswithmetastaticrenalcellcarcinomatreatedwithcytoreductivenephrectomy
AT seokhokang preoperativecholesterollevelasanewindependentpredictivefactorofsurvivalinpatientswithmetastaticrenalcellcarcinomatreatedwithcytoreductivenephrectomy
AT sunghoohong preoperativecholesterollevelasanewindependentpredictivefactorofsurvivalinpatientswithmetastaticrenalcellcarcinomatreatedwithcytoreductivenephrectomy
AT jinsoochung preoperativecholesterollevelasanewindependentpredictivefactorofsurvivalinpatientswithmetastaticrenalcellcarcinomatreatedwithcytoreductivenephrectomy
AT taegyunkwon preoperativecholesterollevelasanewindependentpredictivefactorofsurvivalinpatientswithmetastaticrenalcellcarcinomatreatedwithcytoreductivenephrectomy
AT cheolkwak preoperativecholesterollevelasanewindependentpredictivefactorofsurvivalinpatientswithmetastaticrenalcellcarcinomatreatedwithcytoreductivenephrectomy
AT hyeonhoekim preoperativecholesterollevelasanewindependentpredictivefactorofsurvivalinpatientswithmetastaticrenalcellcarcinomatreatedwithcytoreductivenephrectomy
AT jongjinoh preoperativecholesterollevelasanewindependentpredictivefactorofsurvivalinpatientswithmetastaticrenalcellcarcinomatreatedwithcytoreductivenephrectomy
AT sangchullee preoperativecholesterollevelasanewindependentpredictivefactorofsurvivalinpatientswithmetastaticrenalcellcarcinomatreatedwithcytoreductivenephrectomy
AT sungkyuhong preoperativecholesterollevelasanewindependentpredictivefactorofsurvivalinpatientswithmetastaticrenalcellcarcinomatreatedwithcytoreductivenephrectomy
AT sangeunlee preoperativecholesterollevelasanewindependentpredictivefactorofsurvivalinpatientswithmetastaticrenalcellcarcinomatreatedwithcytoreductivenephrectomy
AT seoksoobyun preoperativecholesterollevelasanewindependentpredictivefactorofsurvivalinpatientswithmetastaticrenalcellcarcinomatreatedwithcytoreductivenephrectomy
AT koreanrenalcellcarcinomakorccgroup preoperativecholesterollevelasanewindependentpredictivefactorofsurvivalinpatientswithmetastaticrenalcellcarcinomatreatedwithcytoreductivenephrectomy